High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

Author： Yeh K-H.   Lin M-T.   Lin D-T.   Tang J-L.   Lui L-T.   Lin J-F.   Chang Y-S.   Cheng A-L.   Yu S-C.   Chang K-J.   Chen Y-C.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.49, Iss.3, 1998-06, pp. : 237-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

By Haas R.   Schmid H.   Hahn U.   Hohaus S.   Goldschmidt H.   Murea S.   Kaufmann M.   Wannenmacher M.   Wallwiener D.   Bastert G.   Hunstein W.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 372-378

Elsevier

Access to resources Recommend Favorite

The Toxicity of Radiotherapy Following High-dose Chemotherapy With Peripheral Blood Stem Cell Support in High-risk Breast Cancer: A Preliminary Analysis

By van der Wall E.   Schaake-Koning C.C.E.   van Zandwijk N.   Baars J.W.   Schornagel J.H.   Richel D.J.   Rutgers E.J.T.   Borger J.H.   Beijnen J.H.   Rodenhuis S.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1490-1497

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

By Engelhardt M.   Zeiser R.   Ihorst G.   Finke J.   Müller C.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 1, 2007-01 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

By Gluck S.   Germond C.   Lopez P.   Cano P.   Dorreen M.   Koski T.   Arnold A.   Dulude H.   Gallant G.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1008-1014

Elsevier

Access to resources Recommend Favorite

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

By Schuster Michael  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite